Staff

Fulvio Adorni

Primo Ricercatore
Application Areas
Research Areas
Research Lines
Projects
E-Mail

fulviodaniele.adorni@cnr.it

PHONE

+390226422629

LOCATION

Segrate

ROOM (floor/number)

6/18

Senior Researcher and Head of the Epidemiology Unit at ITB CNR, I have over 30 years of experience in epidemiology, biostatistics, and biomedical informatics. My research focuses on infectious, metabolic, and neurodegenerative diseases, with a strong interest in disease mechanisms, risk factors, and prevention. I have led national and international projects. My expertise spans study design, advanced statistical modeling, real world data analysis, and digital health interventions. I have extensive experience in systematic reviews, meta analyses, and scientific coordination. I develop research-oriented software and databases and support population-based analyses using health information systems. I contribute to scientific committees, DSMBs, institutional boards, and national working groups on epidemiology and occupational health. My work integrates rigorous methodology with interdisciplinary collaboration. I am committed to improving public health through evidence-based research. My goal is to translate data into meaningful insights for prevention, healthy aging, and better clinical outcomes.

Epidemiological studies of infectious diseases (HIV/AIDS, TB, hepatitis B and C) in clinical and non-clinical cohorts, including natural history, disease progression monitoring, immunological, genetic and epidemiological risk factors, efficacy/effectiveness and safety of pharmacological interventions, drug-induced mutations/resistance.

Study of neurodegenerative diseases (i.e. cognitive impairment, dementia, Alzheimer's disease, Parkinson's disease) focused on identification of modifiable risk factors (e.g. lifestyles), disease assessment and progression.

Observational study of health determinants in an Italian population, using pooled real-world data and electronic health records.

Prospective population-based studies that examine how infection exposures and vaccination influence immune response and health outcomes.

Nested case-control study that analyses ‘real world data’ of the Italian National Health System (SSN) to explore the association between exposure to certain medications and onset of diseases (e.g. dementia or cancer).

Identification of risks and protective factors as to develop effective prevention strategies aimed at reducing the public health burden of diseases (e.g. RSV and SARS-CoV-2).